Global Animal Antibiotics and Antimicrobials Market could grow significantly over 2023-2032, driven by the rising consumption and uptake of animal-based proteins.
The increasing global demand for animal-derived protein products, coupled with the growing population, has led to a rise in intensive animal farming practices, thereby increasing the risk of disease outbreaks. This necessitates using antibiotics and antimicrobials to prevent and treat infections in livestock, which will propel market revenue in the long run. The rising prevalence of zoonotic diseases and the need for disease control measures further contribute to market growth.
Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/5608
According to CDC, scientists estimate that over 6 out of every 10 known infectious illnesses in humans can be transmitted from animals, and 3 out of every 4 new or emerging infectious diseases in people spread from animals. Additionally, favorable government regulations promoting the judicious use of antibiotics and the implementation of strict guidelines for animal health management play a crucial role in shaping the market.
The overall animal antibiotics and antimicrobials market is segregated based on product, mode of delivery, animal, and region.
In terms of product, the market share from the penicillin segment will expand at a decent CAGR from 2023 to 2032. The demand for penicillin is growing due to its effectiveness in treating a wide range of bacterial infections. Penicillin is considered a first-line antibiotic and is highly effective against various bacteria, including streptococci and staphylococci. Besides, the rise of antibiotic-resistant bacteria has created a need for potent antibiotics like penicillin, further driving its demand in the medical field.
Based on the mode of delivery, the animal antibiotics and antimicrobials market size from the oral solutions segment will register appreciable growth over 2023-2032. Oral solutions offer convenient administration and are effective in treating and preventing infections in livestock. Moreover, they enable precise dosage control and facilitate the treatment of large groups of animals, making them a preferred choice for veterinary professionals and livestock farmers. The ease of oral administration and the potential for improved animal health outcomes contribute to the increasing demand for these products in the animal agriculture industry.
With respect to animal, the livestock animal segment will amass a notable share of the animal antibiotics and antimicrobials industry by 2032, attributed to the rising global demand for animal protein products. As intensive farming practices become more prevalent, the risk of disease outbreaks increases, necessitating the use of antibiotics and antimicrobials to prevent and treat infections. Effective disease control measures and improved animal health outcomes drive the demand for these products in the livestock industry.
Regionally, the Asia Pacific animal antibiotics and antimicrobials will accumulate appreciable gains through 2032. Rapid urbanization and the expanding middle class are leading to increased consumption of animal protein, driving the need for effective disease prevention and treatment in livestock. Additionally, the rise of intensive farming practices and the growing awareness of animal health and welfare contribute to the rising demand for these products in the region.
Request for customization @ https://www.gminsights.com/roc/5608
Table of Contents (ToC) of the report:
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data Sources
1.4.1 Secondary
1.4.1.1 Paid sources
1.4.1.2 Public sources
1.4.2 Primary
Chapter 2 Executive Summary
2.1 Animal antibiotics and antimicrobials 3600 synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product type trends
2.5 Mode of delivery trends
2.6 Animal type trends
Browse complete Table of Contents (ToC) of this research report @ https://www.gminsights.com/toc/detail/animal-antibiotics-and-antimicrobials-market
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Aashit Tiwari
Corporate Sales, USA
Global Market Insights Inc.
Toll Free: 1-888-689-0688
USA: +1-302-846-7766
Europe: +44-742-759-8484
APAC: +65-3129-7718
Email:[email protected]
Market Research Future (MRFR) has published a research report about global animal antibiotics and antimicrobials market that estimates rise for this market with 4.50% CAGR (Compound Annual Growth Rate) for this market between 2017 and 2023.
Evaluating market size and calculating the revenue, this report covers and observes the competitive developments of market players that include joint ventures, new product developments, mergers and acquisitions, research and developments (R & D), and strategic alliances.
However, growing resistance to anti microbials and antibiotics opportunities can restrain the market growth.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/6680Segmentation:The global animal antibiotics and antimicrobials market has been segmented on the basis of delivery type, end user type, product type, and region.
Based on delivery type, this market has been segmented into injections, oral powder, oral solutions, premixes, and others.
Segmentation based on product type segments the market into aminocoumarins, aminoglycosides, bicyclomycin, cephalosporins, fluoroquinolones, fusidic acid, macrolides, penicillin, phenicols, sulfonamides, and tetracyclines.Regional Analysis:The regional segmentation of the global animal antibiotics and antimicrobials market segments the market into continent-based regional markets known as The Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA).The Americas always have the potential to be the largest regional market.
North America anyways alone is capable of emerging as the largest market due to its strong economies are known as the United States of America (USA) and Canada.
Market growth can largely be attributed to the rising demand for animal-derived food products, increasing incidence of zoonotic diseases, and the implementation of regulations to prevent the spread of animal diseases.
The untapped emerging markets such as China, India, and Brazil and growth in the overall companion animal population are also expected to offer significant growth opportunities to market players in the coming yearsThe global "Animal Antibiotics and Antimicrobials Market is projected to reach USD 5.6 billion by 2026 from USD 4.7 billion in 2021, at a CAGR of 3.6% from 2021 to 2026.Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=25161353However, the limited number of new antibiotics, growing resistance to antimicrobials and antibiotics, and increasing good husbandry and hygiene practices are expected to hinder the growth of this market to a certain extent.The Tetracyclines segment accounted for the largest market share in 2020.Based on products, the global animal antimicrobials and antibiotics market is segmented into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobial and antibiotic products.
In 2020, the tetracyclines segment accounted for 48.9% of the global animal antimicrobials and antibiotics market.
Tetracyclines exhibit advantages such as the highest potency against pathogenic microorganisms, are well-absorbed, show low toxicity, and are relatively inexpensive compared to other animal antimicrobial and antibiotic products.
These advantages contribute to the large share of this product segment.
The fluoroquinolones segment is expected to grow at the highest CAGR of 8.0% during the forecast period.
Global Animal Antibiotics and Antimicrobials Market Research Report Information by Delivery Type (Injections, Oral powder, Oral solutions, Premixes, Others), Product Type (Aminocoumarins, Aminoglycosides, Bicyclomycin, etc) and Region - Forecast To 2027.Overview:Animal antibiotics and antimicrobials are needed to cure bacterial infections.
Animal antibiotics and antimicrobials are used to treat the husbandry of livestock when they are found ill, or any one of them is suffering in a herd to prevent further spreading of the disease.
These are also used to increase production.The global animal antibiotics and antimicrobials market is expected to benefit from factors such as its contribution to the food & beverage industry, healthcare sector, pet care sector, and others.
In human healthcare, the segment can contribute impressively by creating antibacterial that would increase resistance against any kind of bacterial infection.
The food producing animals segment is substantially big and invites a lot of investments on which it can thrive later.Based on the product type, the animal antibiotics and antimicrobials market can be segmented into aminoglycosides, aminocoumarins, cephalosporins, bicyclomycin, fluoroquinolones, macrolides, penicillin, sulfonamides, phenicols, fusidic acid, and tetracyclines.Regional Analysis:MRFR in their latest report on the regional segmentation of the global animal antibiotics and antimicrobials market includes the Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA) as a part of their intent to study it based on continent-wise production.The Americas, due to advanced medical facilities, research facilities, and investments on the animal-based products is holding immense potential.
Mostly, it is Germany, France, Spain, Italy, and the United Kingdom (UK), who are contributing considerably to the progress of the regional market.The APAC is mostly untapped, but its potential is immense.
Animal Antibiotics and Antimicrobials Market Size Snapshot:In the Healthcare industry, medicines and antibiotics have always been used to cure bacterial infection.
Such medicines are made not just from plant extracts but also from animal extracts.
Currently, the global Animal Antibiotics and Antimicrobials Market Size is expected to grow between the forecast period between 2017 and 2023 with the 4.50% CAGR (Compound Annual Growth Rate).
In terms of cash, the market that is worth US $ 3.9 bn in 2017 is expected to be worth US $ 5.2 bn in 2023.Global Animal Antibiotics and Antimicrobials Market Size Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making.
This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability.
It provides information on trends and developments, and focuses on Markets and materials, capacities and technologies, and on the changing structure of the Serotonin Supplements Market.Some of the key players operating for the global market analysis are Bayer Animal Health, Bioniche Animal Health, Ceva Sante Animale S.A., Elanco Animal Health, Fort Dodge Animal Health, Merck Animal Health, Merial, Novartis Animal Health, Phibro Animal Health Corp., Virbac Animal Health, and Zoetis.Animal Antibiotics and Antimicrobials Market Size Research Coverage:Changing market dynamics of the industryTo get a comprehensive overview of the Animal Antibiotics and Antimicrobials Market Size.Historical, current and projected market size in terms of volume and valueIn-depth market segmentationCompetitive landscapeThe report presents an all-inclusive database in a systematic and highly comprehensive manner.
